¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÉÀåÇÐȸ 2019 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ : 2019-04-20

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽÉÀåÇÐȸ 2019 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ : 2019-04-20
±³À°ÀÏÀÚ : 2019-04-20
±³À°Àå¼Ò : º¤½ºÄÚ 104È£ ¿Ü  
±³À°ÁÖÁ¦ : 2019 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
´ã´çÀÚ : Á¶À±ÇÏ
¿¬¶ôó : 02-3275-5258  
À̸ÞÀÏ : herz8@circulation.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í »çÀüµî·Ï: ±³¼ö ¹× °³¿øÀÇ 100,000¿ø/ÀüÀÓÀÇ, Àü°øÀÇ, ±âŸ 70,000¿ø ´çÀϵî·Ï: ±³¼ö ¹× °³¿øÀÇ 120,000¿ø/ÀüÀÓÀÇ, Àü°øÀÇ, ±âŸ 90,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-20 104È£ 09:00~09:12 Vascular Access for Coronary Intervention - TFI, TRI, Distal Radial  ÀÌÁØ¿ø(¿¬¼¼¿øÁÖÀÇ´ë) 
±³À°½Ã°£ 04-20 104È£ 09:12~09:24 Vascular Access for Non-Coronary Intervention - TFI, TRI, Brachial, Others  °íÃæ¿ø(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 04-20 104È£ 09:24~09:36 Hemostasis: A to Z  ÇãÁ¤È£(°í½ÅÀÇ´ë) 
±³À°½Ã°£ 04-20 104È£ 09:36~09:48 How to Solve Access Site Problems  À¯»ó¿ë(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 04-20 104È£ 09:48~10:00 Tips & Tricks of Vascular Access  ÀÌÀçȯ(Ãæ³²ÀÇ´ë) 
Åä·Ð 04-20 104È£ 10:00~10:30 Discussion  () 
È޽Ġ04-20  10:30~10:40 Break  () 
±³À°½Ã°£ 04-20 203È£ 10:40~10:55 Role of Myocardial Strain Imaging in Acyanotic CHD  ¿ÀÁøÈñ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04-20 203È£ 10:55~11:10 Funtional Assessment Before and after VAD in Children with CHD  Á¤¼¼¿ë(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04-20 203È£ 11:10~11:25 How to Manage the Patients with Pulmonary Venous Obstruction in TAPVR : Pre-op & Post-op  ÀÌ»óÀ±(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04-20 203È£ 11:25~11:55 Integrated Imaging Approach to Pulmonary Venous Obstruction  Shi-Joon Yoo(Univ. of Toronto Canada) 
Åä·Ð 04-20 203È£ 11:55~12:10 Discussion  () 
È޽Ġ04-20  12:10~12:15 Break  () 
±³À°½Ã°£ 04-20 201È£ 12:15~12:55 PIONEER-HF: Prime Time for ARNI in Stabilized AHF Patients  Eric Velazquez(Yale University USA) 
È޽Ġ04-20  12:55~13:10 Break  () 
±³À°½Ã°£ 04-20 205È£ 13:10~13:18 Pacing Maneuvers for SVT Differentiation  ±è¼ºÈ¯(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04-20 205È£ 13:18~13:26 Treatment of PSVT  ±èÁ¾À±(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04-20 205È£ 13:26~13:34 How I Overcame a Challenging Case of PSVT?  ¿À¼¼ÀÏ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04-20 205È£ 13:34~13:42 EKG localization: outflow VT  ÁøÀº¼±(°æÈñÀÇ´ë) 
±³À°½Ã°£ 04-20 205È£ 13:42~13:50 EKG localization: non-outflow VT  ¿Â¿µ±Ù(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 04-20 205È£ 13:50~13:58 Pharmacologic treatment of VT  ±èÀ¯¸®(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04-20 205È£ 13:58~14:06 Neuromodulation in refractory ventricular arrhythmia  ¹Ú°æ¹Î(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 04-20 205È£ 14:06~14:14 New Technique and Technologies in VT Ablation  ±èÁØ(¿ï»êÀÇ´ë) 
Åä·Ð 04-20 205È£ 14:14~14:40 Discussion  () 
È޽Ġ04-20  14:40~14:50 Break  () 
±³À°½Ã°£ 04-20 103È£ 14:50~15:10 What Is the Best Prognosticator in HF?: Imaging vs. Biomarker  ÃÖÁ¤Çö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 04-20 103È£ 15:10~15:30 Cardiac Cath Will Guide the Course and Management for HF  ÀÌÁÖÈñ(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 04-20 103È£ 15:30~15:50 Imaging in Athletes: How to Differentiate with Pathology?  ¼±º´ÁÖ(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 04-20 103È£ 15:50~16:10 How to Use Cardiac Imaging for Therapeutic Guideline in HF  ¾çµ¿Çå(°æºÏÀÇ´ë) 
Åä·Ð 04-20 103È£ 16:10~16:20 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÉÀåÇÐȸ 2019 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ : 2019-04-20""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼­¿ï´ëÇб³º´¿ø 2019³â Á¦19ȸ ´ëÇÑÀü¸³¼±·¹ÀÌÀú¿¬±¸ÇÐȸ ÁýÁß½ÉÆ÷Áö¿ò : 2019-04-20
´ÙÀ½±Û ´ëÇѾȽŰæÀÇÇÐȸ 2019³â Ãá°èÇмú´ëȸ (Neurology of eye movements) : 2019-04-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
19952 °æ±â °í·Á´ëÇб³¾È»êº´¿ø ¾È»ê ¹× ½ÃÈ­Áö¿ª À̺ñÀÎÈÄ°ú Àǻ縦 À§ÇÑ Áý´ãȸ : 2024-03-29 0 91 2024-02-25
19951 ¼­¿ï (¿Â¶óÀÎ) Á¦35Â÷ ´ëÇÑÀÇ·á°ü·Ã°¨¿°°ü¸®ÇÐȸ ¿¬¼ö°úÁ¤_±âº»,½ÉÈ­°úÁ¤(2ÀÏÂ÷) : 2024-03-29 0 77 2024-02-25
19950 Á¦ÁÖ ´ëÇѾȰúÇÐȸ Á¦131ȸ Çмú´ëȸ - 1ÀÏÂ÷ : 2024-03-29 0 112 2024-02-25
19949 ´ë±¸ ´ëÇѺ´¸®ÇÐȸ ´ë±¸°æºÏÁöºÎÇÐȸ : 2024-03-28 0 54 2024-02-25
19948 ¼­¿ï (¿Â¶óÀÎ) Á¦35Â÷ ´ëÇÑÀÇ·á°ü·Ã°¨¿°°ü¸®ÇÐȸ ¿¬¼ö°úÁ¤_±âº»,½ÉÈ­°úÁ¤(1ÀÏÂ÷) : 2024-03-28 0 36 2024-02-25
19947 °æ±â Á¦2Â÷ ¿¬¼¼ÀÇ´ë À̺ñÀÎÈÄ°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-03-27 0 33 2024-02-25
19946 ´ë±¸ ¾îÁö·³ÁõÀÇ Áø´Ü°ú Ä¡·á : 2024-03-26 0 42 2024-02-25
19945 ±¤ÁÖ Á¦180Â÷ ´ëÇѼҾÆû¼Ò³â°úÇÐȸ ±¤ÁÖ¡¤Àü³²Áöȸ ÇмúÁý´ãȸ : 2024-03-26 0 38 2024-02-25
19944 ÃæºÏ ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ Understanding Current Community Mental Health and Emotional Disorders in ASD : 2024-03-25 0 32 2024-02-25
19943 ¼­¿ï ÇѾç´ëÇб³º´¿ø »êºÎÀΰú °³¿øÀǸ¦ À§ÇÑ Æ¯º° ¿¬¼ö°­Á : 2024-03-24 0 46 2024-02-25
19942 °æ±â Á¦ 26ȸ ¾ÆÁִ뺴¿ø ³»°úºÎ °³¿øÀÇ ¿¬¼ö°­Á : 2024-03-24 0 45 2024-02-25
19941 ´ë±¸ 2024 °è¸í´ëÇб³ µ¿»êº´¿ø »êºÎÀΰú Á¦26Â÷ ¿¬¼ö°­Á : 2024-03-24 0 117 2024-02-25
19940 ¼­¿ï (¿Â¶óÀÎ) Á¦69ȸ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ¼¼¹Ì³ª : 2024-03-24 0 48 2024-02-25
19939 ´ë±¸ Á¦27Â÷ ´ëÇѽÉÀåÇÐȸ ´ë±¸°æºÏÁöȸ ÀÓ»ó½ÉÀåÇÐ ¿¬¼ö°­Á : 2024-03-24 0 18,682 2024-02-24
19938 ¼­¿ï 2024 ´ëÇÑÀÓ»óÅëÇÕÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-03-24 1 992 2024-02-24
81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷